Some of these other issues can improve so that I will be able to get off of some of these other medications because thats the whole thing
This is simply a conversation where you can share your health history, current challenges, and what you hope to achieve
In clinical studies, higher levels of circulating long- and medium-chain acylcarnitines showed mixed results in patients with Alzheimers disease [24, 25] whereas clinical trials of patients with Parkinsons disease have consistently shown that circulating levels of long-chain acylcarnitines are decreased [26,27,28]
Those two numbers, 27 and 30, form the backbone of every eligibility conversation you will ever have about GLP-1 medications
Complex I activity was measured with the Complex I Enzyme Activity Kit (Abcam ab109721)
We do not prescribe medications online without a prior in-person evaluation